RxDoctor Payments DataLook up a doctor →

Russell Carr, MD

Family Medicine · Shreveport, LANPI 1245205335

Payments from drug & device makers

$17,447in general payments, 2019–2025

Across 1,137 payments — averaging $15.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • AstraZeneca$2K
  • Lilly USA, LLC$1K
  • Boehringer Ingelheim$984
  • Novo Nordisk$946
  • Amgen$921
  • plus $9K from 53 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)254$2,963
AstraZeneca(2 entities)107$1,761
Lilly USA, LLC85$1,251
Boehringer Ingelheim68$984
Novo Nordisk59$946
Amgen(2 entities)57$921
Pfizer63$868
GSK48$787
Takeda Pharmaceuticals U.S.A., Inc.49$759
Merck47$662
Bayer28$517
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC28$404
Daiichi Sankyo Inc.12$378
Axsome Therapeutics, Inc.17$342
Astellas Pharma US Inc10$289
Johnson & Johnson22$271
Amarin Pharma, Inc.15$254
Kowa Pharmaceuticals America, Inc.14$198
Ironshore Pharmaceuticals Inc.9$182
Biohaven Pharmaceutical Holding Company Ltd.9$175
Sanofi-aventis U.S. LLC13$174
Lundbeck LLC8$169
Phathom Pharmaceuticals, Inc.8$163
Biohaven Pharmaceuticals, Inc.10$145
Sunovion Pharmaceuticals Inc.1$125
Corium, LLC5$121
Teva Pharmaceuticals USA, Inc.8$118
Dexcom, Inc.5$108
Supernus Pharmaceuticals, Inc.5$105
Otsuka America Pharmaceutical, Inc.5$102
Avanir Pharmaceuticals, Inc.5$89
Abbott6$88
Sumitomo Pharma America, Inc.2$85
Exact Sciences4$74
IBSA Pharma Inc.4$72
Shield Therapeutics Inc4$70
Corcept Therapeutics3$66
Collegium Pharmaceutical, Inc.4$62
Shire North American Group Inc4$60
Upsher-smith Laboratories LLC4$57
Idorsia Pharmaceuticals US Inc3$55
Ardelyx, Inc.3$53
Recor Medical Inc2$37
Tris Pharma Inc2$33
Abiomed1$32
Arbor Pharmaceuticals, Inc.2$32
Neos Therapeutics, LP2$30
Eisai Inc.2$24
Vanda Pharmaceuticals Inc.1$21
Antares Pharma, Inc.1$20
Xeris Pharmaceuticals, Inc.1$19
Itamar Medical Inc1$18
Jazz Pharmaceuticals Inc.1$18
Harmony Biosciences LLC1$16
Boston Scientific1$16
Adlon Therapeutics L.p.1$16
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$14
Inogen, Inc.1$13
Esperion Therapeutics, Inc.1$12

How this compares

$17,447 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana →

Medicare billing

Part B allowed, 2024
$47,801
Medicare patients
120
Services billed
5,253

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Shreveport

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →